Anne Gondouin
Besancon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Phenotypes and outcome of diffuse pulmonary non-amyloid light chain deposition disease.
Journal: Respiratory research
Published: October 18, 2023
French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2021 update. Full-length version.
Journal: Respiratory medicine and research
Published: January 11, 2023
Immunoglobulins as a treatment modality for corticosteroid-refractory pemetrexed-induced interstitial lung disease, case report.
Journal: Respiratory medicine and research
Published: October 27, 2022
Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial.
Journal: The European respiratory journal
Published: October 27, 2022
French practical guidelines for the diagnosis and management of IPF - 2021 update, full version
Journal: Revue des maladies respiratoires
Published: June 25, 2022
French practical guidelines for the diagnosis and management of IPF - 2021 update, short version
Journal: Revue des maladies respiratoires
Published: March 19, 2022
Bird fancier's lung serodiagnosis by automated r-IgLL1 ELISA.
Journal: Journal of immunological methods
Published: December 03, 2021
Interstitial lung diseases associated with mutations of poly(A)-specific ribonuclease: A multicentre retrospective study.
Journal: Respirology (Carlton, Vic.)
Published: September 04, 2021
Treatment of Idiopathic Pulmonary Fibrosis with Capsule or Tablet Formulations of Pirfenidone in the Real-Life French RaDiCo-ILD Cohort.
Journal: Advances in therapy
Published: August 20, 2021
Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trial.
Journal: The European respiratory journal
Published: August 10, 2021
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: The Lancet. Respiratory medicine
Published: June 05, 2021
Gender Differences in Idiopathic Pulmonary Fibrosis: Are Men and Women Equal?
Journal: Frontiers in medicine
Published: May 23, 2021
Last Updated: 09/26/2026